• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肢体威胁性缺血患者手术与血管腔内血运重建术后基于肢体的通畅情况

Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia.

作者信息

Utsunomiya Makoto, Takahara Mitsuyoshi, Iida Osamu, Soga Yoshimitsu, Hata Yosuke, Shiraki Tatsuya, Nagae Ayumu, Kato Tamon, Kobayashi Norihiro, Suematsu Nobuhiro, Tasaki Junichi, Horie Kazunori, Uchida Daiki, Kodama Akio, Azuma Nobuyoshi, Nakamura Masato

机构信息

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.

Department of Metabolic Medicine and Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

J Endovasc Ther. 2020 Aug;27(4):584-594. doi: 10.1177/1526602820923388. Epub 2020 May 20.

DOI:10.1177/1526602820923388
PMID:32431246
Abstract

PURPOSE

To determine whether limb-based patency (LBP) after infrainguinal revascularization for chronic limb-threatening ischemia (CLTI) is similar between bypass surgery and endovascular therapy (EVT).

MATERIALS AND METHODS

The database for the urgical Reconstruction vs eripheral tervention in Ptients With Critical Limb Isemia (SPINACH) study was interrogated to identify 130 patients (mean age 73±8 years; 94 men) who underwent bypass surgery and 271 patients (mean age 74±10 years; 178 men) who underwent EVT alone. Skin perfusion pressure (SPP) and the ankle-brachial index (ABI) were measured before the procedure and at 0, 1, and 3 months after revascularization. The outcome measure was hemodynamically evaluated LBP (SPP ≥10 mm Hg or ABI ≥0.1) maintained over the first 3 months after treatment. Any reintervention or major amputation was regarded as loss of LBP. The associations between the revascularization strategy (bypass vs EVT) and between the preoperative characteristics and the study outcome (ie, SPP- or ABI-based LBP), were determined using generalized linear mixed models with a logit link function. Patency rates are presented with the 95% confidence interval (CI).

RESULTS

The bypass surgery group had a higher stage of limb severity (WIfI) and anatomic complexity (GLASS) than the EVT group, whereas the EVT group had a higher prevalence of heart failure. Both SPP- and ABI-based LBP rates were higher in the bypass group than in the EVT group. SPP-based LBP rates at 3 months were 73.8% (95% CI 63.4% to 84.2%) in the bypass group and 46.2% (95% CI 38.5% to 53.8%) in the EVT group; the corresponding ABI-based LBP rates were 71.5% (95% CI 61.8% to 81.2%) and 44.0% (95% CI 37.3% to 50.7%).

CONCLUSION

LBP is an important concept in the new global vascular guidelines for assessing the anatomic and hemodynamic status of CLTI patients. The present study found that LBP was significantly lower in the EVT group vs the bypass surgery group.

摘要

目的

确定慢性肢体威胁性缺血(CLTI)患者行股动脉以下血管重建术后基于肢体的通畅率(LBP)在旁路手术和血管内治疗(EVT)之间是否相似。

材料与方法

查询严重肢体缺血患者手术重建与外周干预(SPINACH)研究的数据库,以确定130例行旁路手术的患者(平均年龄73±8岁;94例男性)和271例仅接受EVT的患者(平均年龄74±10岁;178例男性)。在手术前以及血管重建术后0、1和3个月测量皮肤灌注压(SPP)和踝臂指数(ABI)。结局指标是在治疗后的前3个月内通过血流动力学评估维持的LBP(SPP≥10 mmHg或ABI≥0.1)。任何再次干预或大截肢均视为LBP丧失。使用具有logit链接函数的广义线性混合模型确定血管重建策略(旁路手术与EVT)之间以及术前特征与研究结局(即基于SPP或ABI的LBP)之间的关联。通畅率以95%置信区间(CI)表示。

结果

旁路手术组的肢体严重程度(WIfI)和解剖复杂性(GLASS)阶段高于EVT组,而EVT组心力衰竭的患病率更高。基于SPP和ABI的LBP率在旁路手术组均高于EVT组。旁路手术组3个月时基于SPP的LBP率为73.8%(95%CI 63.4%至84.2%),EVT组为46.2%(95%CI 38.5%至53.8%);相应的基于ABI的LBP率分别为71.5%(95%CI 61.8%至81.2%)和44.0%(95%CI 37.3%至50.7%)。

结论

LBP是新的全球血管指南中评估CLTI患者解剖和血流动力学状态的重要概念。本研究发现,EVT组的LBP明显低于旁路手术组。

相似文献

1
Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血患者手术与血管腔内血运重建术后基于肢体的通畅情况
J Endovasc Ther. 2020 Aug;27(4):584-594. doi: 10.1177/1526602820923388. Epub 2020 May 20.
2
Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.肢体通畅作为慢性肢体缺血性疾病有效血运重建的衡量指标。
J Vasc Surg. 2022 Oct;76(4):997-1005.e2. doi: 10.1016/j.jvs.2022.04.042. Epub 2022 Jun 10.
3
Outcomes and Patency of Endovascular Infrapopliteal Reinterventions in Patients With Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血患者血管腔内再干预的结果和通畅率。
J Endovasc Ther. 2024 Oct;31(5):831-839. doi: 10.1177/15266028221147457. Epub 2023 Jan 7.
4
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.对于因膝下动脉疾病导致慢性肢体威胁性缺血的患者,采用旁路优先与血管内优先策略的临床结果。
J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244.
5
The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.全球肢体解剖分期系统与慢性肢体威胁性缺血症的下肢血运重建治疗结局相关。
J Vasc Surg. 2021 Jun;73(6):2009-2020.e4. doi: 10.1016/j.jvs.2020.12.094. Epub 2021 Feb 4.
6
Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients.下肢动脉旁路手术与血管腔内治疗在中高危患者慢性肢体缺血性疾病中的应用比较
J Vasc Surg. 2024 Jul;80(1):204-212.e3. doi: 10.1016/j.jvs.2024.03.025. Epub 2024 Mar 24.
7
Validation of the Global Limb Anatomic Staging System in first-time lower extremity revascularization.全球肢体解剖分期系统在首次下肢血运重建中的验证。
J Vasc Surg. 2021 May;73(5):1683-1691.e1. doi: 10.1016/j.jvs.2020.08.151. Epub 2020 Oct 20.
8
Treatment outcomes between bypass surgery and endovascular therapy in patients with chronic limb-threatening ischemia classified as bypass-preferred category based on Global Vascular Guidelines.基于全球血管指南分类为旁路首选类别的慢性肢体缺血威胁性患者中旁路手术与血管内治疗的治疗结局。
J Vasc Surg. 2023 Aug;78(2):475-482.e1. doi: 10.1016/j.jvs.2023.04.006. Epub 2023 Apr 17.
9
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.慢性肢体严重缺血患者行下肢血运重建术的生存预测。
J Vasc Surg. 2019 Jun;69(6S):137S-151S.e3. doi: 10.1016/j.jvs.2018.08.169. Epub 2018 Nov 26.
10
Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.慢性肢体威胁性缺血患者股腘病变开放和血管内再通后免于截肢的生存率、肢体症状缓解率和再介入率。
J Vasc Surg. 2020 Dec;72(6):1987-1995. doi: 10.1016/j.jvs.2020.03.029. Epub 2020 Apr 8.

引用本文的文献

1
Clinical Outcomes after Revascularization in Patients with Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血患者血管重建后的临床结局
Ann Vasc Dis. 2025;18(1). doi: 10.3400/avd.ra.24-00135. Epub 2025 Jan 20.
2
Anatomical and clinical factors associated with infrapopliteal arterial bypass outcomes in patients with chronic limb-threatening ischemia.与慢性肢体威胁性缺血患者的腘下动脉旁路手术结果相关的解剖和临床因素。
Heart Vessels. 2024 Nov;39(11):928-938. doi: 10.1007/s00380-024-02421-6. Epub 2024 Jun 6.
3
Role of the Global Limb Anatomic Staging System in predicting outcomes of chronic limb-threatening ischemia in patients treated by drug-coated balloons.
全球肢体解剖分期系统在预测接受药物涂层球囊治疗的慢性肢体威胁性缺血患者预后中的作用。
Quant Imaging Med Surg. 2023 Mar 1;13(3):1350-1359. doi: 10.21037/qims-22-715. Epub 2022 Nov 30.
4
Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.用于血管腔内治疗股腘动脉闭塞症或慢性肢体威胁性缺血的眼眶斑块旋切术的三年疗效
J Endovasc Ther. 2020 Oct;27(5):714-725. doi: 10.1177/1526602820935611. Epub 2020 Jul 3.